Mayne Pharma Group Ltd
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of MYX-AX would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2007) — listing | $11,499 0.4× | $16,610 0.4× |
| Year 6 (2012) | $7,686 0.4× | $11,106 0.4× |
| Year 11 (2017) | $5,743 0.4× | $8,284 0.4× |
| Year 16 (2022) | $3,699 0.6× | $5,346 0.6× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Salisbury, Australia
Popular scenarios with MYX
For illustration only — not investment advice. Past performance is not indicative of future results.